About This Page
This is a clinician-written, evidence-based guide aligned to the MCC Examination Objectives. It is structured by clinical presentation — the way the MCCQE tests and the way patients actually present. Management reflects current Canadian guidelines (CMA, CFPC, CPS). Always cross-reference with institutional protocols and clinical judgment.
The Bottom Line
- Pain assessment is diagnostic and therapeutic: site, onset, quality, radiation, severity, function, mood, sleep, red flags, medications, substance use, and patient goals
- Acute severe pain can signal ACS, dissection, perforation, ischemic limb/bowel, spinal cord compression, meningitis, compartment syndrome, or necrotizing infection
- Classify mechanism: nociceptive, inflammatory, visceral, neuropathic, cancer-related, nociplastic, or mixed pain
- Use multimodal analgesia: non-pharmacologic measures, acetaminophen, NSAIDs where safe, topical agents, neuropathic agents, procedures, and cautious opioid use
- For chronic non-cancer pain, Canadian opioid guidance emphasizes optimized non-opioid therapy first, functional goals, dose caution, and careful monitoring
Approach to the Presentation
Pain is both a symptom and a biopsychosocial experience. MCCQE1 questions test whether candidates recognize dangerous pain, communicate effectively, and prescribe safely. Begin with ABCs and red flags for acute pain. Then classify mechanism: nociceptive somatic, visceral, neuropathic, inflammatory, cancer-related, or nociplastic/central sensitization. Assess intensity, function, sleep, mood, trauma, occupational context, prior treatments, substance use, pregnancy, renal/hepatic disease, anticoagulation, and patient priorities. In chronic pain, avoid escalating opioids without diagnosis, functional plan, mental health assessment, and risk mitigation.
Differential Diagnosis
| diagnosis | likelihood | key features | distinguishing test |
|---|---|---|---|
| Life-threatening acute pain syndrome | must-not-miss | Chest tearing/pressure, sudden severe abdominal pain, severe headache, limb pain with pallor/pulselessness, pain out of proportion, neurological deficit | Targeted emergency workup: ECG/troponin, CTA, CT abdomen, neuroimaging/LP, vascular imaging, surgical assessment |
| Spinal cord compression / cauda equina syndrome | must-not-miss | Back pain with weakness, saddle anaesthesia, urinary retention/incontinence, cancer history, fever, IV drug use | Urgent MRI spine and neurosurgical/oncology assessment |
| Cancer-related pain | must-not-miss | Persistent progressive pain, night pain, weight loss, known cancer, bone pain, neurological symptoms | Targeted imaging, CBC/calcium/ALP, oncology/palliative assessment |
| Opioid use disorder or unsafe opioid use | must-not-miss | Loss of control, cravings, early refills, sedation, overdose history, concurrent benzodiazepines/alcohol, diversion concerns | Clinical DSM-5 assessment, pharmacy records/PDMP where available, urine drug testing when clinically appropriate |
| Nociceptive musculoskeletal pain | common | Localized aching pain after injury/overuse, worse with movement, tenderness, preserved neurological exam | Clinical diagnosis; imaging only if trauma/red flags or management-changing findings |
| Inflammatory pain | common | Morning stiffness >30-60 min, swelling, warmth, systemic symptoms, improvement with activity | ESR/CRP, joint exam, targeted autoimmune tests/imaging |
| Neuropathic pain | common | Burning, shooting, electric pain, numbness, allodynia; diabetes, shingles, radiculopathy, chemotherapy | Neurological exam; glucose/B12/TSH as indicated; imaging if compressive red flags |
| Visceral pain | common | Poorly localized cramping/colicky pain, nausea/vomiting, autonomic features, referred pain | Location-specific labs/imaging: LFTs/lipase/urinalysis/pregnancy test/ultrasound/CT |
| Nociplastic pain / fibromyalgia phenotype | common | Widespread pain, fatigue, poor sleep, cognitive symptoms, hypersensitivity, normal inflammatory tests | Clinical diagnosis after red flags excluded |
| Psychological and social amplification of pain | common | Pain worsened by depression, anxiety, trauma, sleep deprivation, work stress, isolation, compensation stressors | Biopsychosocial assessment; PHQ-9/GAD-7/PTSD screen as appropriate |
Red Flags & Key History
Symptoms
Sudden worst-ever pain, tearing pain, chest pain, syncope, neurological deficit, or dyspnea
Back pain with bladder/bowel dysfunction, saddle anaesthesia, progressive weakness, fever, or cancer history
Pain out of proportion, rapidly progressive swelling, fever, bullae, or crepitus
New severe pain in pregnancy, anticoagulated patient, immunosuppressed patient, or older adult after fall
Burning/electric quality, allodynia, dermatomal radiation
Morning stiffness and swelling
Sleep disruption, mood symptoms, trauma history, functional avoidance
Signs
Objective neurological deficit, hyperreflexia, saddle sensory loss, urinary retention
Peritonitis, pulseless limb, compartment firmness, septic appearance
Sedation, respiratory depression, pinpoint pupils
Swollen warm joint, reduced range of motion, fever
Allodynia, hyperalgesia, sensory loss in a nerve/root distribution
Approach to Investigation
First-line
Pain and function assessmentUse location, mechanism, severity, sleep, mood, function, medication history, goals, and red flags. PEG scale can be practical in chronic pain
Focused examinationNeurological, vascular, abdominal, joint, spine, skin, and mental status exam depending on presentation
Basic labs only when indicatedCBC/CRP for infection/inflammation, creatinine/LFTs before NSAIDs or many analgesics, pregnancy test before imaging/medications when relevant
Medication/substance risk reviewCheck opioids, benzodiazepines, alcohol, cannabis, gabapentinoids, sedatives, renal/hepatic function, and falls risk
Second-line
Targeted imagingX-ray for trauma/fracture, MRI for cord/cauda equina or infection/cancer red flags, CT/ultrasound for visceral causes; avoid routine imaging for uncomplicated low back pain
Neuropathic/metabolic testingHbA1c/glucose, B12, TSH, SPEP or other tests only when compatible with neuropathy pattern
Opioid safety toolsTreatment agreement, urine drug testing, pharmacy records/PDMP where available, and naloxone discussion for higher-risk opioid prescribing
Specialist
Pain clinic / physiatry / physiotherapyComplex chronic pain with functional impairment despite primary care multimodal management
Addiction medicineSuspected opioid use disorder, unsafe opioid use, benzodiazepine co-use, overdose risk, or difficulty tapering
Palliative careAdvanced cancer or life-limiting illness with complex pain, dyspnea, existential distress, or caregiver strain
Management Principles
2017 Canadian Guideline for Opioid Therapy and Chronic Non-Cancer Pain1
Acute pain
- Treat the dangerous cause first; analgesia should not be withheld while diagnosis proceeds
- Use acetaminophen and NSAIDs when safe; consider topical NSAIDs, ice/heat, immobilisation, nerve blocks, or procedural analgesia
- Use short-course opioids only for severe acute pain when non-opioids are inadequate or contraindicated
- Counsel about driving, alcohol, sedatives, storage, disposal, constipation, and nausea
2
Chronic non-cancer pain
- Set functional goals: walking, sleep, work, caregiving, mood, and self-management rather than pain elimination
- Prioritise education, pacing, physiotherapy, exercise, CBT/ACT, sleep, weight, and ergonomics
- Use mechanism-based medicines: NSAIDs/topicals for inflammatory/nociceptive pain when safe; TCAs/SNRIs/gabapentinoids for selected neuropathic pain
- Avoid initiating long-term opioids until non-opioid therapy is optimized and risks/benefits are discussed
3
Opioid stewardship
- Screen for substance use disorder, mental illness, overdose risk, sleep apnea, benzodiazepines, and alcohol use before opioids
- Use one prescriber/one pharmacy where possible and review effectiveness and harms regularly
- Avoid high-dose escalation; Canadian guidance strongly recommends restricting chronic non-cancer opioid dosing to less than 90 mg morphine equivalents daily
- Offer naloxone education for higher-risk patients and households
4
Communication and equity
- Validate pain while explaining the limits and risks of medication-only approaches
- Use trauma-informed care and avoid stigmatizing language
- Address financial barriers to physiotherapy, medications, transport, and assistive devices
Complications & Pitfalls
- Analgesia avoidance: Treating pain does not prevent diagnosis; uncontrolled pain worsens distress and examination quality.
- Opioid escalation without goals: Chronic pain treatment should improve function, not just numerical pain scores.
- Missed red flags: Severe back pain with bladder symptoms is cauda equina until proven otherwise.
- Unsafe co-prescribing: Opioids plus benzodiazepines, alcohol, gabapentinoids, or sleep apnea increase overdose risk.
- Stigma: Patients with substance use disorder still require compassionate analgesia and evidence-based addiction care.
MCCQE1 Exam Tips
- 1Acute severe pain with instability: resuscitate, investigate the dangerous cause, and give analgesia
- 2Chronic non-cancer pain: non-opioid and non-pharmacologic therapy first; opioids require risk assessment, goals, monitoring, and dose caution
- 3Cauda equina red flags = urgent MRI and surgical referral
- 4Neuropathic pain clues are burning, shooting, electric pain and allodynia
- 5Choosing Wisely-style trap: routine imaging for uncomplicated low back pain without red flags is inappropriate
- 6CanMEDS communicator role: validate pain while setting realistic functional goals and discussing opioid harms
- 7Palliative pain is different from chronic non-cancer pain — comfort and goals of care may justify earlier opioid use with proactive side-effect management
practicetest your knowledge on pain management (acute & chronic pain approach)Apply what you've learnt with MCCQE1-style questions from the iatroX Q-Bank — general & constitutional and beyond.
open q-bank